Rituximab Product Approval Information - Licensing Action
Proper name: Rituximab
Tradename: Rituxan
Manufacturer: Genentech, Inc, South San Francisco, CA, License #1048
Indication for Use: Treatment of patients with relapsed or refractory low-grade or follicular, B-cell non-Hodgkin's lymphoma
Approval Date: 11/26/97
Type of submission: Biologics license application
Approval Letter - PDF
Label - PDF
Reviews (PDF)
page number 20 posted 9/9/98]
Product (9 pages)